PRQR icon

ProQR Therapeutics

29 hedge funds and large institutions have $46.9M invested in ProQR Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$5K +$5K +1,000 New
HHMI
27
Howard Hughes Medical Institute
Maryland
$3K -$302 -70 -9%
TRCT
28
Tower Research Capital (TRC)
New York
$3K +$2.47K +515 +464%
Creative Planning
29
Creative Planning
Kansas
$2K
Viking Global Investors
30
Viking Global Investors
Connecticut
-$5.05M -581,668 Closed
SFM
31
Sphera Funds Management
Israel
-$1.3M -150,000 Closed
PC
32
Polar Capital
United Kingdom
-$260K -30,000 Closed
ARTA
33
A.R.T. Advisors
New York
-$244K -28,202 Closed
SIM
34
Spark Investment Management
New York
-$190K -21,900 Closed
Citadel Advisors
35
Citadel Advisors
Florida
-$103K -11,960 Closed
UBS Group
36
UBS Group
Switzerland
-$8K -957 Closed